Cargando…
Imaging in clinical trials
Drug development continues to face challenges to successfully progress the most promising drug candidates through the stages of clinical trials. Given the increasing cost to develop a drug, methods are required to characterise early drug efficacy and safety. Imaging techniques are increasingly used...
Autores principales: | Murphy, P., Koh, D.-M. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
e-Med
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2967134/ https://www.ncbi.nlm.nih.gov/pubmed/20880784 http://dx.doi.org/10.1102/1470-7330.2010.9027 |
Ejemplares similares
-
Diffusion-weighted magnetic resonance imaging for tumour response assessment: why, when and how?
por: Afaq, A., et al.
Publicado: (2010) -
Whole-body diffusion-weighted imaging in lymphoma
por: Lin, C., et al.
Publicado: (2010) -
PET/CT and breast cancer
por: Hegarty, C., et al.
Publicado: (2010) -
Staging cancer of the pancreas
por: Morana, G., et al.
Publicado: (2010) -
[(18)F]2-Fluoro-2-deoxy-d-glucose PET/CT in mediastinal masses
por: Rankin, S.
Publicado: (2010)